| Date | Form | Description | Docs | XBRL | Pages |
| 11/15/12 | CT ORDER | Confidential treatment order |
|
1 | |
| 11/08/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 | |
| 11/08/12 | 8-K | Current report filing |
|
20 | |
| 11/06/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 | |
| 10/29/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 10/12/12 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
52 | |
| 10/10/12 | 8-K | Current report filing |
|
20 | |
| 10/10/12 | 8-K | Current report filing |
|
3 | |
| 10/02/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/28/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...